EU Eureka Innowwide
Overview
EU Eureka Innowwide is a public funding programme managed by the Eureka Network and funded by the European Union, which provides grants to innovative SMEs to assess the viability of their research or commercial plans in international markets.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| MJN Neuroservis | Jan 2020 | Grant | Co-investor |
| Levels Diagnostics | Oct 2019 | Grant | Co-investor |
| gMendel | Nov 2023 | Grant | Co-investor |
| Sanzar Group | Jun 2025 | Grant | Co-investor |
| CardioID Technologies | Jun 2026 | Grant | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is EU Eureka Innowwide based?
EU Eureka Innowwide is headquartered in Brussels, Belgium.
When was EU Eureka Innowwide founded?
EU Eureka Innowwide was founded in 2022.
How many portfolio companies does EU Eureka Innowwide have?
EU Eureka Innowwide has 8 portfolio companies in Caplight's dataset.
What are some companies in EU Eureka Innowwide's portfolio?
Portfolio companies visible on Caplight include MJN Neuroservis, Levels Diagnostics, gMendel, Sanzar Group, CardioID Technologies.
What was EU Eureka Innowwide's most recent investment shown here?
EU Eureka Innowwide's most recent investment in this portfolio sample was in CardioID Technologies in 2026.
What sectors does EU Eureka Innowwide focus on?
EU Eureka Innowwide focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Enterprise Software, Cybersecurity, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Enterprise Software, Enterprise Software, AI, Data & Cloud Infrastructure.
What company stages does EU Eureka Innowwide focus on?
Stage focus information for EU Eureka Innowwide is not publicly available.